Project Grant R01HD113612

Award Date 9/13/24
Completion Date 7/31/29
Dollars Obligated $830K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is providing $2,468,757 to the University of Texas at Austin to conduct research on using magnetic resonance imaging (MRI) to assess maternal and fetal pancreas size and growth over the course of pregnancy. The research aims to establish a model for how maternal pancreas growth interacts with the...
This Project Grant award, funded by the Department of Health and Human Services' National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), provides $324,883 to support a pilot trial of an intervention to improve initial type 2 diabetes self-management among younger adults with children. The project aims to develop an effective behavior change intervention that can influence long-term diabetes-related health outcomes during the critical first year following...
This $1,450,820 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports clinical studies investigating the use of the Ilet Bionic Pancreas in pregnancy for individuals with type 1 and type 2 diabetes. The grant recipient, The General Hospital Corporation (doing business as Massachusetts General Hospital), will conduct a 5-week crossover trial in non-pregnant individuals...
This federal Project Grant award of $319,990 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a 12-week randomized controlled trial to compare medical nutrition therapy personalized by continuous glucose monitoring (CGM) feedback to three control interventions in 72 adult participants with type 2 diabetes mellitus. The primary objective is to determine if CGM-informed personalized...
This federal Project Grant award from the National Institute of Nursing Research (NINR) under CFDA 93.361 (Nursing Research) aims to study the impact of the REDDCAT2 intervention on readmission risk and health outcomes for patients with type 2 diabetes. The $2,271,519 award to the University of Massachusetts Medical School will fund the development and implementation of a comprehensive screening tool (REDD-CAT) and patient navigation protocol to identify and address social determinants of health...
This National Science Foundation (NSF) Division of Social and Economic Science Project Grant awarded to Emory University for $231,685 examines how different organizations, such as medical clinics, technology companies, and schools, influence access to and use of medical devices for youth with diabetes. The two-phased project focuses on continuous glucose monitoring (CGM) devices and insulin pumps, investigating how these organizations and their interactions shape health inequities in the use...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $147,459 to the University of California, Berkeley to conduct research addressing racial and ethnic disparities in diabetes risk following varying glycemia levels during pregnancy. The key objectives are to: 1) Ascertain the risk of future diabetes after gestational diabetes mellitus (GDM) and...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $990,990 project grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Integrated Medical Sensors Inc., a minority-owned small disadvantaged business located in Irvine, CA. The project aims to optimize the manufacturing and quality framework for the company's miniaturized, integrated continuous glucose monitoring (CGM+) platform in preparation for larger human...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to quantify the impact of hyperglycemia on embryonic metabolism and development in C. elegans. The $474,878 award to the Children's Hospital Medical Center in Cincinnati, Ohio will support a 2-year research project to generate single-cell resolution data on how embryonic metabolism changes over developmental...
This $1.2 million project grant from the National Science Foundation's Engineering program (CFDA 47.041) will fund research at Stanford University from September 2022 to August 2026 to develop digital tools and algorithms to improve diabetes care delivery and health equity. Specifically, the university will leverage sensor data and machine learning techniques to better understand patient types and needs, allocate limited provider resources efficiently, and design interpretable treatment...

This $829,637 Project Grant awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to determine the effectiveness of real-time continuous glucose monitoring (CGM) at reducing maternal and neonatal morbidity and mortality in pregnant individuals with type 2 diabetes. The research will define adequate glycemic control targets for CGM and self-monitoring of blood glucose, and identify social determinants of health associated with disparities in outcomes for this population. The University of Alabama at Birmingham is the prime awardee, with sub-awards to the University of Texas Health Science Center at Houston, University of North Carolina at Chapel Hill, Prisma Health - Upstate, University of California, San Diego, and the University of Pennsylvania to support various aspects of the study.

Generated 7/1/25, 5:30 AM